Maness S C, McDonnell D P, Gaido K W
Chemical Industry Institute of Toxicology, Research Triangle Park, North Carolina, 27709, USA.
Toxicol Appl Pharmacol. 1998 Jul;151(1):135-42. doi: 10.1006/taap.1998.8431.
Recent reports have raised new concerns that chemicals in our environment may disrupt normal reproduction and development through inhibition of androgen receptor function. This heightened concern has also increased our need for methods that allow us to characterize chemical interaction with the androgen receptor. In this report we describe an androgen receptor assay that utilizes the HepG2 human hepatoma cell line transiently transfected with the human androgen receptor and an androgen-responsive reporter. We used this assay to characterize the interaction with the androgen receptor of several steroidal and nonsteroidal chemicals, including isomers of DDT and methoxychlor. Chemicals were tested either in the absence (for determining agonist activity) or presence of 10(-7) M dihydrotestosterone (for determining antagonist activity). Testosterone and dihydrotestosterone were equally potent agonists in this assay. Estradiol and progesterone displayed partial agonist/antagonist activity. Flutamide was a complete agonist, whereas its hydroxylated metabolite, hydroxyflutamide, only partially antagonized and displayed some agonist activity at 10(-6) M and above. o,p'-DDT, o,p'-DDE, o,p'-DDD, p,p'-DDT, p,p'-DDE, and p, p'-DDD all behaved as antagonists at concentrations above 10(-6) M. p,p'-DDE also showed some agonist activity at 10(-5) M. Methoxychlor was only weakly antagonistic while its hydroxylated metabolite, HPTE, was approximately 10-fold more potent. Our results demonstrate that the HepG2 assay is a sensitive and specific method for detecting chemical interaction with the androgen receptor. This reporter gene assay, which we have used to characterize interaction with both the estrogen and androgen receptors, coupled with more extensive in vivo studies, should be useful for determining the role of multiple steroid receptors in the mechanism of action of endocrine active chemicals.
最近的报告引发了新的担忧,即我们环境中的化学物质可能通过抑制雄激素受体功能来干扰正常的生殖和发育。这种日益增加的担忧也使我们更加需要能够表征化学物质与雄激素受体相互作用的方法。在本报告中,我们描述了一种雄激素受体检测方法,该方法利用瞬时转染了人雄激素受体和雄激素反应性报告基因的HepG2人肝癌细胞系。我们使用该检测方法来表征几种甾体和非甾体化学物质与雄激素受体的相互作用,包括滴滴涕(DDT)和甲氧滴滴涕的异构体。化学物质在不存在(用于确定激动剂活性)或存在10⁻⁷ M二氢睾酮(用于确定拮抗剂活性)的情况下进行测试。睾酮和二氢睾酮在该检测中是同等效力的激动剂。雌二醇和孕酮表现出部分激动剂/拮抗剂活性。氟他胺是一种完全激动剂,而其羟基化代谢物羟基氟他胺仅部分拮抗,并在10⁻⁶ M及以上浓度时表现出一些激动剂活性。o,p'-DDT、o,p'-DDE、o,p'-DDD、p,p'-DDT、p,p'-DDE和p,p'-DDD在浓度高于10⁻⁶ M时均表现为拮抗剂。p,p'-DDE在10⁻⁵ M时也表现出一些激动剂活性。甲氧滴滴涕仅具有微弱的拮抗作用,而其羟基化代谢物HPTE的效力约高10倍。我们的结果表明,HepG2检测是一种检测化学物质与雄激素受体相互作用的灵敏且特异的方法。这种报告基因检测方法,我们已用于表征与雌激素和雄激素受体的相互作用,并结合更广泛的体内研究,应该有助于确定多种类固醇受体在内分泌活性化学物质作用机制中的作用。